vs

Side-by-side financial comparison of FRP HOLDINGS, INC. (FRPH) and Gossamer Bio, Inc. (GOSS). Click either name above to swap in a different company.

Gossamer Bio, Inc. is the larger business by last-quarter revenue ($13.8M vs $10.9M, roughly 1.3× FRP HOLDINGS, INC.). FRP HOLDINGS, INC. runs the higher net margin — 1.3% vs -342.3%, a 343.6% gap on every dollar of revenue. On growth, Gossamer Bio, Inc. posted the faster year-over-year revenue change (47.1% vs 3.6%).

FRP Advisory is a business advisory firm based in the United Kingdom, providing restructuring, corporate finance, debt advisory, forensic accounting and financial advisory and is one of the UK’s largest specialists in the area of corporate restructuring.

Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics for patients with serious immunology, inflammation and oncology conditions. It advances a pipeline of proprietary product candidates across multiple clinical phases, primarily serving healthcare markets in North America and other global regions.

FRPH vs GOSS — Head-to-Head

Bigger by revenue
GOSS
GOSS
1.3× larger
GOSS
$13.8M
$10.9M
FRPH
Growing faster (revenue YoY)
GOSS
GOSS
+43.5% gap
GOSS
47.1%
3.6%
FRPH
Higher net margin
FRPH
FRPH
343.6% more per $
FRPH
1.3%
-342.3%
GOSS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FRPH
FRPH
GOSS
GOSS
Revenue
$10.9M
$13.8M
Net Profit
$139.0K
$-47.2M
Gross Margin
Operating Margin
15.4%
-333.6%
Net Margin
1.3%
-342.3%
Revenue YoY
3.6%
47.1%
Net Profit YoY
-91.8%
-43.0%
EPS (diluted)
$0.03
$-0.21

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FRPH
FRPH
GOSS
GOSS
Q4 25
$10.9M
$13.8M
Q3 25
$10.8M
$13.3M
Q2 25
$10.8M
Q1 25
$10.3M
Q4 24
$10.5M
Q3 24
$10.6M
Q2 24
$10.5M
$95.8M
Q1 24
$10.1M
$0
Net Profit
FRPH
FRPH
GOSS
GOSS
Q4 25
$139.0K
$-47.2M
Q3 25
$662.0K
$-48.2M
Q2 25
$578.0K
Q1 25
$1.7M
Q4 24
$1.7M
Q3 24
$1.4M
Q2 24
$2.0M
$49.2M
Q1 24
$1.3M
$-41.9M
Operating Margin
FRPH
FRPH
GOSS
GOSS
Q4 25
15.4%
-333.6%
Q3 25
12.6%
-369.4%
Q2 25
15.3%
Q1 25
22.6%
Q4 24
27.7%
Q3 24
29.0%
Q2 24
26.9%
54.3%
Q1 24
28.4%
Net Margin
FRPH
FRPH
GOSS
GOSS
Q4 25
1.3%
-342.3%
Q3 25
6.1%
-362.7%
Q2 25
5.3%
Q1 25
16.6%
Q4 24
16.0%
Q3 24
12.8%
Q2 24
19.5%
51.4%
Q1 24
12.8%
EPS (diluted)
FRPH
FRPH
GOSS
GOSS
Q4 25
$0.03
$-0.21
Q3 25
$0.03
$-0.21
Q2 25
$0.03
Q1 25
$0.09
Q4 24
$0.09
Q3 24
$0.07
Q2 24
$0.11
$0.22
Q1 24
$0.07
$-0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FRPH
FRPH
GOSS
GOSS
Cash + ST InvestmentsLiquidity on hand
$136.9M
Total DebtLower is stronger
$192.6M
Stockholders' EquityBook value
$428.5M
$-122.8M
Total Assets
$735.1M
$172.2M
Debt / EquityLower = less leverage
0.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FRPH
FRPH
GOSS
GOSS
Q4 25
$136.9M
Q3 25
$134.9M
$180.2M
Q2 25
$153.2M
Q1 25
$142.9M
Q4 24
$148.6M
Q3 24
$144.7M
Q2 24
$156.9M
$354.5M
Q1 24
$152.5M
$244.4M
Total Debt
FRPH
FRPH
GOSS
GOSS
Q4 25
$192.6M
Q3 25
$185.3M
Q2 25
$180.4M
Q1 25
$178.3M
Q4 24
$178.9M
Q3 24
$178.8M
Q2 24
$178.8M
Q1 24
$178.7M
Stockholders' Equity
FRPH
FRPH
GOSS
GOSS
Q4 25
$428.5M
$-122.8M
Q3 25
$427.7M
$-82.3M
Q2 25
$426.7M
Q1 25
$425.2M
Q4 24
$423.1M
Q3 24
$420.9M
Q2 24
$419.1M
$81.5M
Q1 24
$416.1M
$26.7M
Total Assets
FRPH
FRPH
GOSS
GOSS
Q4 25
$735.1M
$172.2M
Q3 25
$731.3M
$208.8M
Q2 25
$722.8M
Q1 25
$717.1M
Q4 24
$728.5M
Q3 24
$726.9M
Q2 24
$711.9M
$373.4M
Q1 24
$705.7M
$259.4M
Debt / Equity
FRPH
FRPH
GOSS
GOSS
Q4 25
0.45×
Q3 25
0.43×
Q2 25
0.42×
Q1 25
0.42×
Q4 24
0.42×
Q3 24
0.42×
Q2 24
0.43×
Q1 24
0.43×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FRPH
FRPH
GOSS
GOSS
Operating Cash FlowLast quarter
$29.7M
$-48.3M
Free Cash FlowOCF − Capex
$-21.5M
FCF MarginFCF / Revenue
-196.6%
Capex IntensityCapex / Revenue
468.5%
0.0%
Cash ConversionOCF / Net Profit
213.50×
TTM Free Cash FlowTrailing 4 quarters
$-34.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FRPH
FRPH
GOSS
GOSS
Q4 25
$29.7M
$-48.3M
Q3 25
$8.1M
$-36.2M
Q2 25
$8.7M
Q1 25
$4.5M
Q4 24
$29.0M
Q3 24
$6.3M
Q2 24
$12.2M
$116.3M
Q1 24
$2.9M
$-52.3M
Free Cash Flow
FRPH
FRPH
GOSS
GOSS
Q4 25
$-21.5M
Q3 25
$-16.9M
Q2 25
$2.6M
Q1 25
$1.4M
Q4 24
$-22.2M
Q3 24
$-28.2M
Q2 24
$5.9M
Q1 24
$-3.3M
FCF Margin
FRPH
FRPH
GOSS
GOSS
Q4 25
-196.6%
Q3 25
-157.0%
Q2 25
24.0%
Q1 25
13.6%
Q4 24
-210.9%
Q3 24
-265.7%
Q2 24
56.0%
Q1 24
-32.6%
Capex Intensity
FRPH
FRPH
GOSS
GOSS
Q4 25
468.5%
0.0%
Q3 25
232.0%
0.0%
Q2 25
55.9%
Q1 25
30.1%
Q4 24
486.1%
Q3 24
325.1%
Q2 24
60.3%
0.0%
Q1 24
61.2%
Cash Conversion
FRPH
FRPH
GOSS
GOSS
Q4 25
213.50×
Q3 25
12.21×
Q2 25
15.00×
Q1 25
2.63×
Q4 24
17.18×
Q3 24
4.65×
Q2 24
5.96×
2.36×
Q1 24
2.23×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FRPH
FRPH

Other$5.6M51%
Multifamily Segment$5.3M49%

GOSS
GOSS

Segment breakdown not available.

Related Comparisons